Status:
COMPLETED
Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells
Lead Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Collaborating Sponsors:
N.N. Alexandrov National Cancer Centre
Conditions:
Urinary Incontinence
Eligibility:
MALE
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Treatment of patients with urinary incontinence after prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel
Detailed Description
During the implementation of the project, it is planned to develop a method for the treatment of men urinary incontinence caused by prostatectomy using injection of autologous adipose-derived mesenchy...
Eligibility Criteria
Inclusion
- Urinary incontinence
- absence of acute inflammatory manifestations in the genitourinary system
- period after prostatectomy is at least 12 months
Exclusion
- urethral or bladder malformations
- acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
- mental disorders
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04426643
Start Date
August 1 2020
End Date
March 31 2021
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Minsk, Belarus, 220072